Sandro Feriozzi - Concepedia

Author

Sandro Feriozzi

Also Known As

C Massimetti, Esposito Pasquale, Federico Pieruzzi, Feriozzi S, Feriozzi, S, G. Toscano, Lida Tartaglione, Loredana Fazzari, M Praga, Manuel Praga

144

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Ospedale di Belcolle University of Bari Aldo Moro Charles University University of Milano-Bicocca Azienda Ospedaliera San Gerardo

About

Sandro Feriozzi is an author at Ospedale di Belcolle specializing in medicine, pathology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.1K
2	Public Health	4	4	323
3	Biostatistics	2	2	379
4	Engineering	1	1	64
5	Social Sciences	1	1	35

Sandro Feriozzi

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
The MEST score provides earlier risk prediction in lgA nephropathy Sean J. Barbour, Gabriela Espino-Hernández, Heather N. Reich, Kidney International Mest ScoreGlomerulonephritisMedicineKidney FailureLupus Nephritis	2015	279
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial Francesco Scolari, Elisa Delbarba, Domenico Santoro, Journal of the American Society of Nephrology	2021	217
Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference Raphael Schiffmann, Derralynn Hughes, Gabor E. Linthorst, Kidney International	2016	175
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy Krzysztof Kiryluk, Elena Sánchez, Francesca Zanoni, Nature Genetics Genome-wide Association StudyGlomerulonephritisGenome-wide AssociationAutoimmune DiseaseMedicine	2023	156
Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases Chiara Fallerini, Laura Dosa, Rossella Tita, Clinical Genetics Relevant FractionNext GenerationMendelian DisorderGenetic DisorderGenetics	2013	140
Improvement of Renal Function with Selective Thromboxane Antagonism in Lupus Nephritis Alessandro Pierucci, Bianca M. Simonetti, Gabriella Pecci, New England Journal of Medicine	1989	124
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update Rosanna Coppo, Graziella D’Arrigo, Giovanni Tripepi, Nephrology Dialysis Transplantation	2018	105
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy Francesco Paolo Schena, Vito Walter Anelli, Joseph Trotta, Kidney International Glomerular DiseaseArtificial IntelligenceImmunoglobulin A NephropathyDiagnosisNephrology	2020	100
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease? Giovanni Duro, Carmela Zizzo, Giuseppe Cammarata, International Journal of Molecular Sciences Anderson-fabry DiseaseGeneticsGenetic EpidemiologyPathologyMolecular Genetics	2018	96
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy John Feehally, Rosanna Coppo, Stéphan Troyanov, The Nephron journals/Nephron journals	2015	88

Page 1